Gyuzel Y. Mitronova*, , , Christine Quentin, , , Vladimir N. Belov, , , Kamila A. Kiszka, , , Jörg W. Wegener, , and , Stephan E. Lehnart,
{"title":"多靶向咖啡酸衍生物抑制心脏RyR2-和NaV1.5-通道,但刺激SERCA2a泵活性","authors":"Gyuzel Y. Mitronova*, , , Christine Quentin, , , Vladimir N. Belov, , , Kamila A. Kiszka, , , Jörg W. Wegener, , and , Stephan E. Lehnart, ","doi":"10.1021/acsomega.5c04399","DOIUrl":null,"url":null,"abstract":"<p >Heart beat relies on coordinated calcium regulation through RyR2 and SERCA2a activity, as well as impulse propagation mediated by Na<sub>V</sub>1.5 activity. Here, we present small molecules combining a 1,4-benzothia- or 1,4-benzoxazepine scaffold and a 3-(3,4-dihydroxyphenyl)-2-propenoic acid residue of which five compounds (<b>4</b>, <b>9</b>, <b>10</b>, <b>12</b>, and <b>13</b>) reduced cardiac RyR2 activity and stimulated SERCA2a activity in our cell systems. The acceleration of SERCA2 activity was particularly enhanced by cyanoborane derivatives <b>11</b>–<b>13</b>. The substantial impact on SERCA2 activation relates to the presence of polar (zwitterionic) N–B fragments, which can increase the binding affinity to SERCA2 and result in a more efficient activation. Compounds <b>12</b> and <b>13</b> at a concentration of 10 μM additionally reduced Na<sub>V</sub>1.5 activity in Chinese hamster ovary (CHO) cells, indicating a multitargeted drug property. We propose that the multitargeted actions of these novel compounds have the potential to enhance heart failure therapy, particularly in personalized treatment approaches.</p>","PeriodicalId":22,"journal":{"name":"ACS Omega","volume":"10 38","pages":"43831–43854"},"PeriodicalIF":4.3000,"publicationDate":"2025-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://pubs.acs.org/doi/pdf/10.1021/acsomega.5c04399","citationCount":"0","resultStr":"{\"title\":\"Multitargeted Caffeic Acid Derivatives Inhibit Cardiac RyR2- and NaV1.5- Channels but Stimulate SERCA2a Pump Activity\",\"authors\":\"Gyuzel Y. Mitronova*, , , Christine Quentin, , , Vladimir N. Belov, , , Kamila A. Kiszka, , , Jörg W. Wegener, , and , Stephan E. Lehnart, \",\"doi\":\"10.1021/acsomega.5c04399\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p >Heart beat relies on coordinated calcium regulation through RyR2 and SERCA2a activity, as well as impulse propagation mediated by Na<sub>V</sub>1.5 activity. Here, we present small molecules combining a 1,4-benzothia- or 1,4-benzoxazepine scaffold and a 3-(3,4-dihydroxyphenyl)-2-propenoic acid residue of which five compounds (<b>4</b>, <b>9</b>, <b>10</b>, <b>12</b>, and <b>13</b>) reduced cardiac RyR2 activity and stimulated SERCA2a activity in our cell systems. The acceleration of SERCA2 activity was particularly enhanced by cyanoborane derivatives <b>11</b>–<b>13</b>. The substantial impact on SERCA2 activation relates to the presence of polar (zwitterionic) N–B fragments, which can increase the binding affinity to SERCA2 and result in a more efficient activation. Compounds <b>12</b> and <b>13</b> at a concentration of 10 μM additionally reduced Na<sub>V</sub>1.5 activity in Chinese hamster ovary (CHO) cells, indicating a multitargeted drug property. We propose that the multitargeted actions of these novel compounds have the potential to enhance heart failure therapy, particularly in personalized treatment approaches.</p>\",\"PeriodicalId\":22,\"journal\":{\"name\":\"ACS Omega\",\"volume\":\"10 38\",\"pages\":\"43831–43854\"},\"PeriodicalIF\":4.3000,\"publicationDate\":\"2025-09-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://pubs.acs.org/doi/pdf/10.1021/acsomega.5c04399\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACS Omega\",\"FirstCategoryId\":\"92\",\"ListUrlMain\":\"https://pubs.acs.org/doi/10.1021/acsomega.5c04399\",\"RegionNum\":3,\"RegionCategory\":\"化学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CHEMISTRY, MULTIDISCIPLINARY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Omega","FirstCategoryId":"92","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acsomega.5c04399","RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
Multitargeted Caffeic Acid Derivatives Inhibit Cardiac RyR2- and NaV1.5- Channels but Stimulate SERCA2a Pump Activity
Heart beat relies on coordinated calcium regulation through RyR2 and SERCA2a activity, as well as impulse propagation mediated by NaV1.5 activity. Here, we present small molecules combining a 1,4-benzothia- or 1,4-benzoxazepine scaffold and a 3-(3,4-dihydroxyphenyl)-2-propenoic acid residue of which five compounds (4, 9, 10, 12, and 13) reduced cardiac RyR2 activity and stimulated SERCA2a activity in our cell systems. The acceleration of SERCA2 activity was particularly enhanced by cyanoborane derivatives 11–13. The substantial impact on SERCA2 activation relates to the presence of polar (zwitterionic) N–B fragments, which can increase the binding affinity to SERCA2 and result in a more efficient activation. Compounds 12 and 13 at a concentration of 10 μM additionally reduced NaV1.5 activity in Chinese hamster ovary (CHO) cells, indicating a multitargeted drug property. We propose that the multitargeted actions of these novel compounds have the potential to enhance heart failure therapy, particularly in personalized treatment approaches.
ACS OmegaChemical Engineering-General Chemical Engineering
CiteScore
6.60
自引率
4.90%
发文量
3945
审稿时长
2.4 months
期刊介绍:
ACS Omega is an open-access global publication for scientific articles that describe new findings in chemistry and interfacing areas of science, without any perceived evaluation of immediate impact.